Director, Government Affairs & Policy
What’s in it for you?
Reporting to the VP of Government Affairs, Director/Senior Director of Government Affairs & Policy will be responsible for leading the Acceleron Pharma’s state government affairs efforts and providing strategic oversight of the company’s public policy analysis and engagement. You will represent Acceleron with policymakers at the state level and assist in identification of critical opportunities to positively shape the public policy environment.
In this role, you will work closely with the leaders of Acceleron’s Patient Advocacy, U.S. Market Access, Pricing/HEOR and other commercial leaders to identify existing and emerging policy issues and analyze how those issues impact Acceleron and the patients we serve, both now and in the future. You will assist the VP of Government Affairs in crafting multi-faceted, collaborative strategies to shape public policy.
You will help ensure patient access to Acceleron’s medicines by advocating for and advancing policies impacting such areas as: government-funded health care programs (e.g. Medicare and Medicaid), health insurance benefit design, patient assistance programs, rare disease advisory councils, intellectual property and protecting medical innovation. Further, you will also work to educate state policymakers and state officials about the challenges facing patients with rare diseases and the importance of ensuring access to innovative medicines.
You will help to elevate Acceleron’s voice and credibility among the policymaking community with the achievement of strategic objectives, supporting work around a proactive policy agenda and leading the Acceleron U.S. Public Policy Workgroup. You will manage policy and state government affairs consultants and identify opportunities for strategic collaboration with patient advocacy organizations, health care providers, trade associations (such as BIO and MassBIO) and other stakeholders. You will also prioritize compliance with federal and state requirements around lobbying, political giving and disclosure.
Ideally, the role is based either in Cambridge, MA or Washington, D.C.
What will you be doing?
- Develop, lead the execution of and communicate short and long term strategy for elevating Acceleron’s voice, specifically with state government officials.
- Spearhead Acceleron’s public policy analysis efforts through issue identification, research, analysis, assessment and communication.
- Work cross-functionally to identify and develop appropriate position statements and engagement strategies for issues of concern to Acceleron and the patients we serve.
- Advance a proactive public policy agenda and develop and execute state advocacy strategies designed to advance the company’s legislative and regulatory priorities.
- Engage with key lawmakers, regulators and staff to represent Acceleron and its values.
- Serve as a liaison with trade associations, coalitions and partnerships that represent the biopharmaceutical industry and advocate for policies that seek to protect patients’ access to innovative medicines. Participate in committees, work groups and related activities to advocate for Acceleron priorities.
- Demonstrate strong analytic and research skills, including a familiarity with legislative, regulatory and policy materials, as well as significant experience engaging in the health care policymaking process.
What are we looking for?
- BS or BA degree (MA/MPA preferred) and 10 years of prior experience in government, government affairs, or policy role
- Corporate experience in the biotechnology or pharmaceutical industries is preferred
- Experience with state legislatures, U.S. Congress, health care trade associations, governors and state or federal agencies with jurisdiction over healthcare
- Multiple years of experience working as a lobbyist that includes experience with strategy development and execution
- Experience managing and developing a team
- Understanding of the approval, coverage and reimbursement processes for prescription drugs, and applicable intellectual property laws
- Strategic visioning and leadership capabilities
- The candidate should be a self-starter and team-player able to exercise significant discretion and independent strategic discernment
- Strong verbal and written communication abilities, including experience with the use of PowerPoint and related tools to make effective presentations
- Proven ability to build effective relationships with internal and external stakeholders and work as part of a cross-functional team advocating on complex health policy issues
- Willing to travel in the US up to 40%
How will you grow with us?
The opportunity to help build internal government affairs and policy department with high-level visibility and impact both internally and externally. The ability to provide a leadership role as appropriate based on the progress and evolution of Acceleron’s strategic plan and execution needs within a growing corporate affairs department. A position that has strong ability to ensure patients have access to innovative medicines through advancement of positive, patient-centric public policy.
*In compliance with federal law, all persons hired will be required to verify identity and eligibility to work in the United States and complete the required employment eligibility verification document form upon hire.
*Recruiters – please do not send unsolicited resumes to this posting.
FOR IMMEDIATE CONSIDERATION PLEASE SUBMIT YOUR RESUME TO:
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron’s leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body’s ability to regulate cellular growth and repair. Acceleron focuses its commercialization, research, and development efforts in hematologic and pulmonary diseases. In hematology, Acceleron and its global collaboration partner, Bristol Myers Squibb, are co-promoting REBLOZYL® (luspatercept-aamt), the first and only approved erythroid maturation agent, in the United States for the treatment of anemia in certain blood disorders. The Companies are also developing luspatercept for the treatment of chronic anemia in patient populations of MDS, beta-thalassemia, and myelofibrosis. In pulmonary, Acceleron is developing sotatercept for the treatment of pulmonary arterial hypertension, having recently reported positive topline results of the Phase 2 PULSAR trial. For more information, please visit https://acceleronpharma.com. Follow Acceleron on Social Media: @AcceleronPharma and LinkedIn.
Learn more here
Job posted: 2021-07-17